HORIZONFP7H2020
Fondazione Irccs Istituto Nazionale Dei Tumori
- Country
- ITItaly
- Defence projects
- 0
- Projects, all programmes
- 47
- As coordinator
- 7
- EU contribution (CORDIS)
- EUR 18,376,323
- Active
- 2008 to 2025
Projects
47 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| X-eHealthX-eHealth: eXchanging electronic Health Records in a commom framework | H2020 | 2020 | Third party | Not stated |
| SELNETSarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary network | H2020 | 2019 | Participant | EUR 450,000 |
| ONCOBIOMEGut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. | H2020 | 2019 | Participant | EUR 223,750 |
| ITCC-P4ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 | H2020 | 2017 | Third party | Not stated |
| SPIDIA4PSPIDIA for Personalized Medicine - Standardisation of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine | H2020 | 2017 | Participant | EUR 86,877 |
| PREDICTA new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology | H2020 | 2017 | Participant | EUR 386,877 |
| PAIN-NetMolecule-to-man pain network | H2020 | 2017 | Participant | EUR 258,061 |
| BD2DecideBig Data and models for personalized Head and Neck Cancer Decision support | H2020 | 2016 | Participant | EUR 815,000 |
| ICAROColloidal Inorganic Nanostructures for Radiotherapy and Chemotherapy | H2020 | 2016 | Third party | Not stated |
| PRECIOUSScaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy | H2020 | 2016 | Participant | EUR 448,417 |
| TackSHSTackling secondhand tobacco smoke and e-cigarette emissions: exposure assessment, novel interventions, impact on lung diseases and economic burden in diverse European populations. The TackSHS Project. | H2020 | 2015 | Participant | EUR 155,875 |
| GANNET53A drug strategy targeting heat shock protein 90 to combat metastatic, p53 mutant ovarian cancer. | FP7 | 2013 | Participant | EUR 24,500 |
| REQUITEValidating predictive models of radiotherapy toxicity to improve quality-of-life and reduce side-effects in cancer survivors | FP7 | 2013 | Participant | EUR 187,089 |
| IACTImmunostimulatory Agonist antibodies for Cancer Therapy | FP7 | 2013 | Participant | EUR 306,500 |
| MEMEMERandomized controlled trial of metformin and dietary restriction to prevent age-related morbid events in people with metabolic syndrome | FP7 | 2013 | Coordinator | EUR 2,500,000 |
| EPIC-CVDEPIC-CVD: Individualised CVD risk assessment: tailoring targeted and cost-effective approaches to Europe's diverse populations | FP7 | 2012 | Participant | EUR 9,112 |
| IMMUNOCANToward enhancing activities of European institutions in the FDUSCC-IM cancer research joint institute in China | FP7 | 2012 | Participant | EUR 165,529 |
| I.FAMILYDeterminants of eating behaviour in European children, adolescents and their parents | FP7 | 2012 | Participant | EUR 132,565 |
| EUROSARCEuropean Clinical trials in Rare Sarcomas within an integrated translational trial network | FP7 | 2011 | Participant | EUR 385,033 |
| NANOSIRNATransfection Ability and Intracellular Pathway of LbL Nanostructured siRNA Delivery Systems | FP7 | 2011 | Coordinator | EUR 16,200 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.